SANUWAVE Health, Inc.: 10-Q filed 2019-11-14
What SANUWAVE Health, Inc. reported in its quarterly report filed 2019-11-14 (fiscal Q3 2019): 38 published measures, 110 facts as tagged in accession 0001654954-19-013014.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-11-14
- Fiscal period
- fiscal Q3 2019
- Accession
- 0001654954-19-013014 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SANUWAVE Health, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 1,644,303 | USD | |
| At 2018-12-31 | 1,177,728 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 14,962,477 | USD | |
| At 2018-12-31 | 16,533,827 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -13,318,174 | USD | |
| At 2019-06-30 | -16,355,506 | USD | |
| At 2019-03-31 | -15,693,947 | USD | |
| At 2018-12-31 | -15,356,099 | USD | |
| At 2018-09-30 | -15,608,790 | USD | |
| At 2018-06-30 | -14,560,166 | USD | |
| At 2018-03-31 | -13,935,396 | USD | |
| At 2017-12-31 | -9,880,827 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 402,656 | USD | |
| At 2018-12-31 | 364,549 | USD | |
| At 2018-09-30 | 72,311 | USD | |
| At 2017-12-31 | 730,184 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -2,748,018 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -7,679,766 | USD | 273 |
| 2019-01-01 to 2019-03-31 | -2,197,317 | USD | 90 |
| 2018-07-01 to 2018-09-30 | -825,142 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -9,570,056 | USD | 273 |
| 2018-04-01 to 2018-06-30 | -2,888,259 | USD | 91 |
| 2018-01-01 to 2018-03-31 | -5,856,655 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -4,684,611 | USD | 273 |
| 2018-01-01 to 2018-09-30 | -2,271,566 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 28,990 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 32,171 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 197,640 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 692,579 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 595,789 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 1,393,271 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 4,738,556 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 1,663,063 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -28,990 | USD | 273 |
| 2018-01-01 to 2018-09-30 | -32,171 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -123,002,883 | USD | |
| At 2018-12-31 | -116,602,778 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 79,300 | USD | |
| At 2018-12-31 | 77,755 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 256,158 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 2,474,496 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -2,385,655 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -6,265,603 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -2,670,356 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -5,913,363 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 958,018 | USD | |
| At 2018-12-31 | 1,083,482 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 182,001 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 1,120,440 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 195,613 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 3,486,878 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 14,544,768 | USD | |
| At 2018-12-31 | 16,487,091 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 1,697,051 | USD | |
| At 2018-12-31 | 1,592,643 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 56,308 | USD | |
| At 2018-12-31 | 234,774 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 2,460,372 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 6,555,525 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 3,082,551 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 6,790,931 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 290,936 | USD | |
| At 2018-12-31 | 357,820 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 74,717 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 289,922 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 412,195 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 877,568 | USD | 273 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 122,923 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 402,657 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 183,594 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 515,703 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 299,903 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 867,825 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 622,152 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 1,339,933 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 245,768,619 | shares | |
| At 2018-12-31 | 155,665,138 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 109,488,657 | USD | |
| At 2018-12-31 | 101,153,882 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -49,716 | USD | |
| At 2018-12-31 | -62,868 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 576,927 | USD | |
| At 2018-12-31 | 0 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 399,449 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 30,058 | USD | |
| At 2018-12-31 | 16,491 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 816,866 | USD | |
| At 2018-12-31 | 689,280 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -2,762,079 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -7,666,614 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -831,372 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -9,587,255 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 1,802,659 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 4,746,519 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 2,244,036 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 5,163,044 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 22,338 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 40,150 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 5,709 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 16,733 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -362,363 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -1,414,163 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 1,845,214 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -3,656,693 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -197,301 | USD | 273 |
| 2018-01-01 to 2018-09-30 | -49,661 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -66,884 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 9,441 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 118,908 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 184,442 | USD | 273 |
Inspect the source
- Entity
- SANUWAVE Health, Inc. / CIK 0001417663
- Captured
- 2026-09-20T08:02:35.518Z
- SEC response SHA-256
51a2d5afc6b3c84f5ebe71aa20944ba7646a9b22810a9cc023a45d564e5104f2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001417663.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))